Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
Danny DvirDidier TchétchéMartin B LeonPhilippe GénéreuxBenjamin SeguyRaj R MakkarPhillippe PibarotHemal GadaTamim M NazifDavid Hildick-SmithJoerg KempfertNicolas DumonteilAxel UnbehaunThomas ModineBrian WhisenantChristophe CaussinLenard ConradiThomas WaggonerJacob M MishellStanley J ChetcutiSaibal KarMichael J RinaldiMolly SzerlipRavi K RamanaDaniel J BlackmanItsik Ben-DorRan KornowskiRon WaksmanUlrich GerckensPaolo DentiMarian KukuckaJulien TernacleSabah SkafJan KovacHasan JilaihawiVivek PatelRami JubehMohamed Abdel-WahabSusheel KodaliPublished in: European heart journal (2024)
Modification of failed bioprosthetic aortic valve leaflets using ShortCut was safe, achieved successful leaflet splitting in all patients, and was associated with favourable clinical outcomes in patients at risk for coronary obstruction undergoing TAVI.
Keyphrases
- aortic valve
- transcatheter aortic valve implantation
- aortic stenosis
- ejection fraction
- end stage renal disease
- aortic valve replacement
- transcatheter aortic valve replacement
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- mitral valve
- coronary artery
- coronary artery disease
- prognostic factors
- heart failure
- atrial fibrillation
- patient reported outcomes